Strategic Acquisition Somnoware is now under ResMed ownership since July 2023, signaling potential access to larger healthcare networks, extended sales cycles, and broader channel opportunities through ResMed's global relationships.

Home Testing Synergy Recent integration with Onera Health to enable home polysomnography and workflow management in Somnoware opens up cross-sell opportunities with sleep diagnostics providers and durable home-based care teams.

Care Management Focus Cloud platform that estimates population risk, manages chronic care, and tracks outcomes aligns well with health systems expanding value-based care contracts; target health systems and accountable care organizations seeking data-driven outcomes.

Partner Ecosystem Existing partnerships with Cerebra for autoscoring and integration capabilities indicate a readiness to augment Somnoware with AI-assisted diagnostics, presenting a pathway for upsell to customers requiring advanced scoring and automation.

Expansion Potential Past product expansions such as fax intake and DME/HST modules demonstrate a pattern of extending workflow integrations; pursue mid-market hospital networks and regional health systems lacking mature sleep and respiratory care IT infrastructure.